Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports
暂无分享,去创建一个
Vincent Vinh-Hung | Jo Caers | C. Oost | V. Vinh-Hung | P. Lacor | Christel Fontaine | Johan Mey | Gerrit Ponnet | Chris Oost | Jan Lamote | Jacques Greve | Benjamin Camp | Patrick Lacor | J. Caers | J. Lamote | C. Fontaine | J. Mey | J. Greve | B. Camp | G. Ponnet | J. Grève
[1] C. Barrios,et al. Evaluation of an implantable venous access system in a general oncology population. , 1992, Oncology.
[2] R. Rosell,et al. Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin) , 1996, Thrombosis and Haemostasis.
[3] J. Lokich,et al. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy , 1983, Cancer.
[4] P. Benotti,et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. , 1990, Annals of internal medicine.
[5] Z. Barley,et al. Tunneled catheter thrombosis: factors related to incidence. , 1990, Oncology nursing forum.
[6] M. Monreal,et al. Pulmonary Embolism in Patients with Upper Extremity DVT Associated to Venous Central Lines - A Prospective Study , 1994, Thrombosis and Haemostasis.
[7] M. De Cicco,et al. Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. , 1995, Thrombosis research.
[8] C. Marsault,et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports , 1993, Cancer.
[9] J. Doppman,et al. Venographic surveillance of tunneled venous access devices in adult oncology patients , 1995, Annals of Surgical Oncology.
[10] J. P. Puig-La Calle,et al. Totally implanted device for long‐term intravenous chemotherapy: Experience in 123 adult patients with solid neoplasms , 1996, Journal of surgical oncology.
[11] S. Laporte,et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. , 2003, Haematologica.
[12] J. Moake,et al. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. , 1985, Oncology.
[13] Stone Mh,et al. Tunneled catheter thrombosis: factors related to incidence. , 1990 .
[14] M. Carlier,et al. Les thromboses veineuses sur cathéter central en cancérologie , 1996 .
[15] H. Kock,et al. Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems , 1998, World Journal of Surgery.
[16] J. Schlangen,et al. A rare complication of implanted central-venous access devices: catheter fracture and embolization , 1995, Supportive Care in Cancer.
[17] M. Gent,et al. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. , 2003, Thrombosis research.
[18] M. Monreal,et al. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. , 1991, Chest.
[19] J. Niederhuber,et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. , 1982, Surgery.
[20] D. Coit,et al. Subcutaneously implanted central venous access devices in cancer patients , 1997, Cancer.
[21] I. B. Rinkes,et al. No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients , 2000, Bone Marrow Transplantation.
[22] B. Eastridge,et al. Complications of indwelling venous access devices in cancer patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Marcus,et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies , 1998, British journal of haematology.
[24] J. C. Pector. Vascular access problems , 1997, Supportive Care in Cancer.
[25] M. De Cicco,et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. , 1997, Thrombosis research.
[26] F. Orsi,et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] L. G. Ortega,et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor. , 1989, Chest.